The Schepens Eye Research Institute. Inc.
Boston, MA Doing business as Schepens Eye Research Institute Inc. Part of Partners Healthcare System Incorporated
- UEI
- XQQJEDK7JC21
- CAGE
- 1NUK9
- Primary NAICS
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Tax Exempt)
- NAICS codes registered in SAM.gov
- Corporate family
-
-
Partners Healthcare System Incorporated
Parent
KH2QJR76KMZ6
- The Schepens Eye Research Institute. Inc. XQQJEDK7JC21
-
Partners Healthcare System Incorporated
Parent
KH2QJR76KMZ6
- SAM.gov registration date
- Physical address
- 20 Staniford St, Boston, MA 02114, USA
- Website
- harvard.edu
- Employees
- 10K-50K
- Estimated annual revenue
- $1B-$10B
- Industry
-
- Consumer Discretionary
- Diversified Consumer Services
- Education Services
- Education
- SIC code
- 82 Educational Services
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Recent federal awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Export and integration of ophthalmic optical coherence tomography data across institutions (OCT) - project… | National Eye Institute | $506,030 | |
| Developing multimodal foundation models for eye disease screening and prognosis - project summary motivation: the… | National Eye Institute | $858,394 | |
| Hormonal dynamics and extracellular vesicle function in keratoconus: exploring pathophysiology and developing targeted… | National Eye Institute | $132,837 | |
| Navigation assistance using multimodal LLM and computer vision - project summary navigation can be a significant… | National Eye Institute | $878,988 | |
| Development of mini-USH2A gene therapy to treat usher syndrome type 2A. - project summary usher syndrome type 2 (USH2)… | National Eye Institute | $881,797 |
About The Schepens Eye Research Institute. Inc.
The Schepens Eye Research Institute, Inc. (doing business as Schepens Eye Research Institute Inc.) is a non-profit, tax-exempt research organization affiliated with Harvard Medical School and Massachusetts Eye and Ear that acts as a federal grant recipient for basic and translational vision research, delivering research findings and scientific data on eye diseases and vision restoration to the National Institutes of Health, the Defense Health Agency, and related federal agencies. Headquartered in Boston, Massachusetts, Schepens operates as a child entity within the Partners Healthcare System and functions almost entirely as a research grant recipient (97% of 198 recent awards are prime grants), with a small sub-award footprint (3%) on collaborative research projects.
Schepens' research portfolio centers on ophthalmology and vision science—specifically corneal disease, retinal disease, glaucoma, and inherited eye conditions. Recent representative work includes a $878,988 National Eye Institute Vision Research award (CFDA 93.867) to develop navigation assistance using multimodal large language models and computer vision for blind and visually impaired individuals; a $881,797 NEI grant for mini-USH2A gene therapy development targeting Usher Syndrome Type 2A; a $1.79 million NEI award for transpalpebral electrical stimulation therapy for diabetic keratopathy; a $1,466,706 Defense Health Agency award for topical oxygen research on chemical eye injuries; and a $1,559,917 National Institute of Neurological Disorders and Stroke grant for NK1R antagonist development as a non-addictive ocular pain treatment. Additional recent work includes research on astrocyte mechanisms in glaucoma, corneal transplant immunology, epigenetic reprogramming in retinal disease, and vaccine platform characterization.
Federal customer concentration is dominated by NIH grant programs. The National Eye Institute alone accounts for 77 awards under its Vision Research program (CFDA 93.867), representing the single largest federal relationship; the broader NIH sponsors 131 awards across multiple institutes and centers when combining the NEI and other NIH units. The Defense Health Agency, the second-ranking customer by potential value, has awarded 19 grants ($3 million combined potential value) focused on military-relevant ocular trauma, chemical injury, and combat vision loss countermeasures. The Department of Veterans Affairs, Department of Health and Human Services, and Department of the Army round out the customer set. Notably, dollar obligations ($369.7 million) substantially exceed combined potential value ($3.8 million), indicating that the source captures only a recent slice of Schepens' active award pipeline and that many of the listed awards are ongoing multi-year grants with phased funding releases.
Activity has fluctuated year over year—11 awards in 2022, 16 in 2023, 9 in 2024, 12 in 2025, and 5 recorded so far in 2026—with 21 awards reaching ultimate completion within the next twenty-four months. The institute carries Indefinite Delivery Contract DAMD1786C6170 (Department of Defense/Defense Health Agency vehicle) supporting at least 4 task orders. Research is performed at the institute's Boston facility with collaboration across Harvard Medical School faculty, Massachusetts Eye and Ear clinicians, and sub-awardee partners including The Johns Hopkins University, Massachusetts General Hospital, Brigham and Women's Hospital, and Harvard College divisions. Schepens' research emphasis on federally funded vision science, coupled with its deep affiliations with Harvard-affiliated clinical and research institutions, positions it as a specialized academic research center serving defense, civilian federal health research, and international development health agendas in ophthalmology and vision restoration.
Quick answers
What is The Schepens Eye Research Institute. Inc.'s UEI?
The Schepens Eye Research Institute. Inc.'s Unique Entity ID (UEI) in SAM.gov is XQQJEDK7JC21.
What is The Schepens Eye Research Institute. Inc.'s CAGE code?
The Schepens Eye Research Institute. Inc.'s CAGE code is 1NUK9.
What is The Schepens Eye Research Institute. Inc.'s primary NAICS code?
The Schepens Eye Research Institute. Inc.'s primary NAICS code is 541715 (Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)).
Where is The Schepens Eye Research Institute. Inc. located?
The Schepens Eye Research Institute. Inc.'s physical address in SAM.gov is 20 Staniford St, Boston, MA 02114, USA.
Is The Schepens Eye Research Institute. Inc. registered in SAM.gov?
Yes. The Schepens Eye Research Institute. Inc.'s SAM.gov registration is active through March 24, 2027.
Who is The Schepens Eye Research Institute. Inc.'s parent company?
The Schepens Eye Research Institute. Inc. is part of Partners Healthcare System Incorporated.
What is The Schepens Eye Research Institute. Inc.'s most recent federal award?
The Schepens Eye Research Institute. Inc.'s most recent federal grant award is Export and integration of ophthalmic optical coherence tomography data across institutions (OCT) - project… (R01EY039476), from National Eye Institute, on September 1, 2026.
On GovTribe
See The Schepens Eye Research Institute. Inc.'s full federal record
- Federal contract awards
- IDV awards
- Federal grant awards
- Subcontracting relationships
- Funding analysis by agency, NAICS and set-aside
- Similar vendors